Navigation Links
Recession Continues to Depress Sales at Allied Healthcare Products
Date:11/6/2009

ST. LOUIS, Nov. 6 /PRNewswire-FirstCall/ -- Recession in domestic and international markets continued to depress sales for Allied Healthcare Products in the first quarter of fiscal year 2010 ending September 30, 2009.

Sales declines pushed Allied into a loss for the quarter. The net loss for the quarter was about $745,000, or negative 9 cents per share, compared to a net profit the year earlier of about $208,000, or 3 cents per share.

Sales fell about 21 percent in the quarter, from about $14.4 million in the first quarter of last year to $11.3 million in the current quarter.

Allied introduced a new product line late in fiscal 2009 - mass casualty ventilators designed for use in pandemics, natural disasters and terrorist attacks. Sales of the new products totaled $500,000 in the quarter.

Allied mass casualty ventilators address needs that traditional, full-featured ventilators do not meet, said Earl Refsland, president and chief executive officer. For example, Allied ventilators cost a fraction of the price of full-featured ventilators, can be operated by non-professionals after brief instruction and are rugged, for use in harsh field conditions. Also, Allied mass casualty ventilators have minimal maintenance requirements, making them ideal for government stockpiles, Refsland said.

A bright spot in the quarter was strong performance in cost reduction efforts in manufacturing and operations. Most of these savings represent long-term reductions that will continue to benefit the company in future quarters.

Allied earnings in the quarter were affected by a non-cash charge of $609,000 resulting from the company's grant to the chief executive officer of an option to purchase 320,000 shares of common stock in the next six years.

Allied Healthcare Products, Inc., manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care
'/>"/>

SOURCE Allied Healthcare Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession
2. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
3. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Despite Recessionary Pressures, Patient and Surgeon Demand Will Drive the Joint Arthroplasty and Fixation Bone Cement Market by 7% Annually Through 2013
6. Shire Continues to Deliver Excellent Growth From Core Products
7. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
8. Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington, D.C.
9. Oppenheimers Investment Bank Continues Expansion -- Lance Alstodt Named Managing Director - Healthcare
10. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
11. Cord Blood America Continues to Reduce Debt; Three Notes Retired

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire...Times article that questions why currently availa... cancers are being ignored, ECRI Institute, an ind...dmap to the evidence on Finasteride for Preventio...he November 13, 2009, New York Times article, " ...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 Warn...he pricing of its previously announced secondary o...price to the public of $22.25 per share. The sell...n Capital Partners, DLJ Merchant Banking, J.P. Mor...H. Lee Partners, L.P., certain other institutional...
(Date:11/19/2009)... , TAINAN, Taiwan, Nov. 19 /PRNewswire-Asi...ive pharmaceutical ingredients (APIs), announced t...mpound Safety Certification from,SafeBridge(R) Con...rm,s,competency and proficiency in the safe handli...Is), and applies to specific laboratories and,prod...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Harold Hank Gardner M D Named in the Future Health 100 56303 1Harold Hank Gardner M D Named in the Future Health 100 56303 2Pharmacists Urge the Public to Begin Getting Immunized 56298 1Pharmacists Urge the Public to Begin Getting Immunized 56298 2Pharmacists Urge the Public to Begin Getting Immunized 56298 3Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 2Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 3
...ive Phase 2a Trial, WALTHAM, Mass., June 12 Repl...that based on feedback from the Food and,Drug Admi...2b clinical,trial of RG2417, an oral formulation o... this year. This will be a multi-center, parallel ...proximately 150 patients with,bipolar disorder wil...
...vement in disease activity through three yea...crease in adverse events, malignancies, infections... over time -, ROCKVILLE, Md., June 12 Human Geno... the presentation of results,from a long- term Pha...R),(belimumab) was associated with sustained impro...
Other Medicine Technology:Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 3Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 4Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 5Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 7
(Date:11/20/2009)..., , NEW YORK, Nov. 20 Re...h report is available in its catalogue. ,, Onc...t Forecast to 2013 ,, http://www.reportlinke...chmarks-and-Market-Forecast-to-2013.html#utm_sourc...newswire ,, Comprehensive Forecasts and Detai...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 Re...h report is available in its catalogue. ,, Ima...ttp://www.reportlinker.com/p0164325/Imaging-Agents...swire&utm_medium=pr&utm_campaign=prnewswir...nized the visualization of organs within the human...
(Date:11/20/2009)..., , HINESBURG, Vt., Nov. 20 K...mpany that specializes in creating sophisticated m...ay announced the launch www.infectioncontrolsourc...care administrators with a comprehensive database ..., "Our mission at Kestrel is to educate healthcar...
(Date:11/20/2009)..., , LOS ANGELES, Nov. 20 As...al feasts, more than 1.25 million people in Los An...rstand the magnitude of the problem, that,s nearly..., people you see every day are hungry - and the si...continues to increase. ,, The Jewish Federatio...
(Date:11/20/2009)...y molecule identified by researchers , ,...may be moving closer to better treatments for bovi...cow disease, and the related condition called Creu...can-1 is crucial to the development of mad cow dis...erstanding its role could help scientists figure o...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9Health News:Infection Prevention Online Community Site Launches - Focused on Product Selection 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 3
...ief that infants' brains don't divide into left-br...study finds the brain's left hemisphere plays the ... beginning almost immediately after birth. Rese...e fMRI has been used to study infants. It is a non...
...osed among men in the United States -- affecting n... treatment options, but new research shows there m... Doctors hope that the drug -- finasteride -- wil... conversion to DHT -- a more active form of the ho...
...ugs used for acute asthma attacks might be causing... studied the use of bronchodilators known as beta-...ry treatment used to relieve acute asthma attacks.... Whatever the mode of administration, they work by...
... blood pressure and heart failure may also benefit...er risk for heart attacks and stroke. Researcher...women from the Heart Outcomes Prevention Evaluatio...ng stroke, peripheral arterial disease, or diabete...
...he risk of dementia , some find light to moderate ... others still find no association at all. In a ... between the ages of 65 and 79 who were followed o...ltogether were both about twice as likely as those...
...ely low body fat whether due to strenuous exercise...from treatment with the appetite-and-weight-regula...ptin may be useful in treating some instances of i...g how much energy is available to the body for imp...
Other Medicine News:Health News:fMRI Offers Insight Into An Infants Brain 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: